Icagen, Inc. 4
4 · Icagen, Inc. · Filed May 20, 2016
Insider Transaction Report
Form 4
Icagen, Inc.NONE
Krafte Douglas
Chief Scientific Officer
Transactions
- Award
Stock Option
2016-05-19+100,000→ 100,000 totalExercise: $3.50From: 2016-05-19Exp: 2026-05-19→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]These options vest as follows: 25,000 vest on June 30, 2016 and the remaining 75,000 vest pro rata on a monthly basis over a three year period.